R&Dplatform

联系我们

国际针灸合作委员会关于变更办公地址的通知

中国民间中医医药研究开发协会国际针灸合作委员会

办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,

同时为方便大家联系,固定电话已经变更

新号码010—58562339。特此通知。

地址:北京西城区西直门南小街国英园一号楼824室

邮编:100035

电话:010-58562339

传真:010-58562339

邮箱:cngjzj@163.com

网站(点击网址直接链接↓):http://www.cngjzj.com/

博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj

交通路线图 (点击观看大图)

到西城区西直门南小街国英园一号楼行驶路线

机场线路1

从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:

1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

机场线路2

从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。

附近公交地铁:

公交官园站:107路,运通106路

公交西直门南:387路,44路,800内环,816路,820内环,845路

地铁车公庄:地铁二号线

地铁西直门:地铁二号线

公交车公庄东:107路,118路,701路

公交车公庄北:209路,375路,392路

您现在的位置是: 首页 >> R&Dplatform >> R&Dplatform

The research and development of the Chinese medicine industry will be an important power

2012年04月27日

复制链接 打印 大 中 小

<

 

 

 

The research and development of the Chinese medicine industry will be an important power

 

 

Author: bank consultant

 

 

 

        In recent years, the development of the industry of Chinese medicine by a negative reports influence, especially in the United States of the traditional Chinese medicine enterprise listed related to withdraw from the market, more have triggered the traditional Chinese medicine industry profitability questioned. But bank advisers say, Chinese traditional medicine industry profitability and have not been affected, on the contrary, Chinese traditional medicine the profitability of products is gradually improving. This is because: one of traditional Chinese medicine industry development present asymmetry, traditional Chinese medicine and traditional Chinese medicine yinpian sales accounted for domestic pharmaceutical more than forty percent of the market, the market is very attractive basis; Second, the Chinese medicine products in China, with a large, fixed consumer groups, traditional Chinese medicine consumption has always maintained a rapid growth; Third, the traditional Chinese medicine industry research and development ability decided the overall level of production, prompted a sharp increase output value related, 2010 1 to 12 months, the cumulative yield nearly 2 million tons of traditional Chinese medicine, more than 21.63% increase over the same period in 2009.

 

        Bank consultant consulting YangWenLiu IPO analysts think that the long-term development of the industry of Chinese power market and policy is the double driver. From a policy perspective, traditional Chinese medicine industry is always the key support of the state industry, the "eleventh five-year plan" period, "Chinese medicine Renaissance" become a national strategy, the development of the industry have more policy resources; In February 2009, the state food and drug administration issued by the bureau of the protection of traditional Chinese medicines guiding principle "; In 2010, the central government budget for the special fund 5.243 billion yuan for the development of the cause of traditional Chinese medicine. This marks the subsequent market development process, the policy will always maintain the industry development potential.

 

        But, Chinese traditional medicine market really good comes from research and development level of investment promotion, research and development of the traditional Chinese medicine industry in our country will become the important direction of future expansion.

        

        The competition from outside the main body to see, the current global pharmaceutical enterprise top 20 have set up special Chinese herbal medicine research center, some firms have started to traditional Chinese medicine in China r&d talents a snare.

 

        From the internal market competition to see, tongren temple, the tai chi group, hua san-jiu, nine of the big cheese hall of traditional Chinese medicine industry group company has become the leading enterprises, the development of enterprise become the the development of the industry benchmarks. This means that China's traditional Chinese medicine market competition tends to be more oligarchs competition, regional market, subdivision medicinal materials will be available to both the market leader market, decided to China's regional market profitability will appear centralization, grading change wait for a phenomenon. In the policy support ability, the market share of the present situation of relative stability, enterprise potential scientific research ability will become the selection of traditional Chinese medicine can be investment enterprise key standards.

 

        Traditional Chinese medicine for edible of basic and clinical efficacy, determine that it has a large market potential and development space, and therefore attracted numerous market from main body. In addition to the drug treatment, Chinese herbal medicine can also be developed into health food, food, beverage, cosmetics, veterinary medicine, Chinese traditional medicine feed additives, these will lead to greater economic and social benefits, will also be the industry's investment gains bring far more than the current yield profit source. It can be inferred that the traditional Chinese medicine market investment in the future will come from research and development ability of Angle innovation, grasp the development in advance for investment will win a bigger profit in return. (bank consultant)

 

        Source: China medical report